Study guide
13.1 Age-Related Macular Degeneration & Retinal Vascular Occlusions
IJCAHPO Certified Retina Technician CRT
Track your progress as you read
Finished sections get a check mark.
1 Exam Overview: Current CRT Requirements & Blueprint
Exam Overview: Current Requirements, Scope & Study Plan
2 Chapter 1: History Taking, Triage & Clinical Documentation
1.1 Comprehensive Ophthalmic & Medical History for Retina Patients 1.2 Telephone Triage, Urgent Symptoms & Emergency Scheduling 1.3 Scribing, Electronic Health Records & Retinal Billing Codes
3 Chapter 2: Visual Assessment & Low Vision Rehabilitation
2.1 Standardized Visual Acuity Testing & Optotypes 2.2 Sub-Chart Acuity Protocols: CF, HM, LP, and NLP 2.3 Low Vision Definitions, Optical Devices & Patient Counseling
4 Chapter 3: Pupil Assessment & Visual Field Testing
3.1 Pupillary Examination & Relative Afferent Pupillary Defect 3.2 Confrontation Fields & Automated Perimetry in Retina 3.3 Amsler Grid Testing & Metamorphopsia Monitoring
5 Chapter 4: Tonometry & Ocular Motility
4.1 Goldmann Applanation & Handheld Tonometry Techniques 4.2 Tonometer Disinfection, Calibration & Post-Procedure IOP Monitoring 4.3 Ocular Motility Assessment, Strabismus & Alignment Testing
6 Chapter 5: Diagnostic Ophthalmic Ultrasound
5.1 Ophthalmic B-Scan Echography for Posterior Segment Pathology 5.2 Standardized A-Scan Echography & Optical Biometry
7 Chapter 6: Slit Lamp, Electrophysiology & Supplemental Testing
6.1 Slit Lamp Biomicroscopy, Illumination & Fundus Lenses 6.2 Color Vision Assessment & Hertel Exophthalmometry 6.3 Ophthalmic Electrophysiology: ERG, VEP, and EOG
8 Chapter 7: Ophthalmic Microbiology & Infection Control
7.1 Ocular Pathogens & Routes of Disease Transmission 7.2 Clinical Asepsis, Universal Precautions & Vitreous Specimen Collection
9 Chapter 8: General Retinal Pharmacology & Therapeutics
8.1 Ocular Drug Delivery Methods & Routes of Administration 8.2 Mydriatics, Cycloplegics & Diagnostic Ophthalmic Dyes 8.3 Anesthetics, Glaucoma Agents & Prescription Verification
10 Chapter 9: Anti-VEGF Therapies, Steroids & Retinal Toxicity
9.1 Anti-VEGF Agents & Neovascular Retinal Diseases 9.2 Corticosteroids, Sustained-Release Implants & AREDS Supplements 9.3 Systemic Medication Retinal Toxicity & Plaquenil Screening
11 Chapter 10: Surgical Assisting & Intravitreal Procedures
10.1 Intravitreal Injection Protocol, Antisepsis & Complication Checks 10.2 Retinal Laser Therapy Modalities & Laser Safety Protocols 10.3 Surgical Instrument Handling, Tray Setup & Sterilization
12 Chapter 11: Patient Services, Education & Clinical Care
11.1 Patient Education, Chronic Disease Counseling & Treatment Adherence 11.2 Special Needs Accommodations, Patient Diversity & Interpersonal Skills 11.3 Ophthalmic Emergencies, First Aid & Clinical Care Coordination 11.4 Clinic Operations, Research Support, Forms & Referrals
13 Chapter 12: General Ocular Anatomy & Retinal Physiology
12.1 Ocular Anatomy, Orbit & Posterior Segment Architecture 12.2 Ten Retinal Layers, Photoreceptors & Macular Anatomy 12.3 Ocular Blood Supply, Microcirculation & Vitreoretinal Interface 12.4 Body Systems, Ocular Adnexa & Medical Terminology
14 Chapter 13: Retinal Pathology & Systemic Disease Manifestations
13.1 Age-Related Macular Degeneration & Retinal Vascular Occlusions 13.2 Diabetic Retinopathy & Systemic Diseases Affecting the Retina 13.3 Peripheral Retinal Degenerations, Tears & Detachments
15 Chapter 14: Ophthalmic Optics & Lensometry
14.1 Principles of Ophthalmic Optics & Refraction 14.2 Manual & Automated Lensometry Techniques
16 Chapter 15: Fundus Photography & Ophthalmic Angiography
15.1 Fundus Photography Techniques & Fundus Autofluorescence 15.2 Fluorescein Angiography Principles, Phases & Image Interpretation 15.3 Indocyanine Green Angiography & Angiographic Complication Management
17 Chapter 16: Optical Coherence Tomography (OCT & OCT-A)
16.1 OCT Principles, Scan Acquisition & Artifact Recognition 16.2 Structural OCT Interpretation: Retinal Fluid & Biomarkers 16.3 Optical Coherence Tomography Angiography (OCT-A) Principles & Flow
18 Chapter 17: Equipment Maintenance, Ethics & Regulatory Compliance
17.1 Equipment Maintenance, Calibration Schedules & Clinic Safety 17.2 Medical Ethics, Scope of Practice & Informed Consent 17.3 Patient Privacy, HIPAA Standards & Hazardous Waste Disposal
13.1 Age-Related Macular Degeneration & Retinal Vascular Occlusions
Key Takeaways Explain This Topic AI
AMD findings include drusen, pigment change, atrophy, fluid, hemorrhage, pigment epithelial detachment, and neovascular tissue; OCT fluid or a PED does not by itself name the complete diagnosis.
Retinal vein occlusion can produce hemorrhage, edema, ischemia, and anterior-segment neovascularization; surveillance is individualized rather than based on a universal 90-day rule.
Sudden painless monocular loss with retinal whitening and a cherry-red spot is compatible with retinal arterial occlusion and triggers immediate emergency and stroke-system evaluation.
In an older patient with possible arterial occlusion, promptly relay headache, scalp tenderness, jaw claudication, fever, weight loss, or polymyalgia symptoms because giant cell arteritis requires urgent evaluation.
Technicians document objective findings and image quality without independently staging ischemia, selecting anti-VEGF therapy, or promising visual recovery.
Last updated: September 2026
AMD and Retinal Vascular Occlusions
Macular degeneration and vascular occlusion are common retina-clinic problems, but imaging findings must be interpreted with the history and examination. The technician's role is accurate acquisition, symptom recognition, documentation, and escalation.
Age-related macular degeneration
AMD affects the macula and is broadly described as non-neovascular or neovascular. Findings may include:
- drusen of different sizes and morphology;
- retinal pigment epithelial pigment change or migration;
- geographic or complete RPE and outer-retinal atrophy;
- intraretinal or subretinal fluid;
- subretinal hyperreflective material or neovascular tissue;
hemorrhage, exudation, fibrosis, or pigment epithelial detachment.
OCT documents fluid compartments and structural change. Fundus photography supports comparison; FAF can map atrophy; fluorescein or ICG may answer vascular questions. A smooth serous PED can occur in several conditions. Overlying fluid or hemorrhage raises concern for activity, but the clinician determines whether the process is neovascular AMD, central serous chorioretinopathy, polypoidal disease, or another entity.
Ask about new distortion, central blur, scotoma, change in reading, and fellow-eye status. New symptoms are routed promptly. Do not tell the patient that one OCT proves the diagnosis or guarantees an injection.
Retinal vein occlusion
A branch retinal vein occlusion follows a branch distribution; a central retinal vein occlusion can produce widespread intraretinal hemorrhage, venous dilation and tortuosity, disc edema, cotton-wool spots, and macular edema. Visual acuity, RAPD, OCT, angiography, and anterior-segment examination help the clinician assess severity and risk.
Ischemia can lead to iris or angle neovascularization and neovascular glaucoma, but older labels such as 90-day glaucoma are not scheduling rules. Neovascularization can develop earlier or later. Follow-up frequency and gonioscopy are clinician-directed from the actual findings, not one fixed disc-area threshold or calendar interval.
The technician records pain, vision, pressure, pupil findings, prior injections or laser, and systemic vascular history. Unexpected pressure rise, corneal edema, iris vessels, or marked pain is escalated promptly.
Retinal artery occlusion
Central or branch retinal arterial occlusion commonly presents with sudden, painless monocular field or vision loss. Diffuse retinal whitening and a cherry-red fovea can appear in central occlusion; a cilioretinal artery may preserve a central island in some eyes. The ocular finding is also a marker of systemic vascular risk.
Current safe triage treats acute retinal arterial ischemia as an emergency requiring immediate stroke-system evaluation. Do not delay transfer for ocular massage or other unproven office maneuvers. Record exact last-known-well time, eye, symptoms, neurologic complaints, medications, and emergency routing.
In patients age 50 or older, ask and immediately relay symptoms of giant cell arteritis such as new headache, scalp tenderness, jaw claudication, fever, weight loss, or shoulder and hip aching. The emergency clinician may order inflammatory markers, platelet count, imaging, or treatment. The technician does not independently order or interpret those tests.
Imaging quality checklist
Confirm correct eye and scan or photographic field.
Center through pupil and avoid lid, lash, motion, and media artifacts.
Inspect OCT segmentation rather than trusting thickness maps alone.
Record dye timing and adverse symptoms for angiography.
Compare with the same prior protocol when possible.
Route a major new hemorrhage, fluid change, neovascular sign, or perfusion concern promptly.
Comparison table
- Pattern Common objective findings Safety focus
- Non-neovascular AMD Drusen, pigment change, atrophy New distortion or scotoma
- Neovascular activity Fluid, hemorrhage, PED, neovascular tissue Prompt clinician review
- Vein occlusion Hemorrhage, dilated veins, edema, ischemia Pressure and neovascular surveillance
- Artery occlusion Sudden loss, whitening, arterial filling problem Immediate emergency stroke pathway
Reliable data and fast routing matter more than a technician-applied label.
Technician observations and urgent routing
For AMD follow-up, acquire the ordered acuity and imaging with consistent device, scan pattern, centering, and registration when possible. Record new distortion, scotoma, hemorrhage symptoms, treatment interval, recent procedure, and adherence without labeling the lesion active or inactive. Segmentation error, poor signal, blink, motion, and decentration can simulate structural change; correct acquisition problems and preserve the original evidence when required.
Sudden painless monocular loss, an altitudinal or diffuse field complaint, or transient monocular blackout may represent arterial ischemia and requires immediate emergency routing under the stroke pathway. A vein occlusion can also present abruptly, but a technician cannot distinguish the vascular diagnosis by symptoms alone. Do not delay emergency evaluation for office maneuvers or promise that massage, pressure lowering, oxygen, or a later clinic visit will restore vision. Ask about neurologic symptoms and, when relevant, giant-cell-arteritis warnings, then relay the answers directly to the clinician or emergency team.